Explore more price target data and ratings for Boston Scientific Corporation on the Forecasts tab, and track all previous and future analyst recommendations for Boston Scientific Corporation in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Syst…
Explore more price target data and ratings for Boston Scientific Corporation on the Forecasts tab, and track all previous and future analyst recommendations for Boston Scientific Corporation in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Syst…
Q2 2026 saw 7% organic sales growth and 15% adjusted EPS growth, but full-year guidance was lowered due to declines in WATCHMAN and EP businesses. A restructuring program aims to deliver $500M in savings by 2029, with growth expected to re-accelerate in 2028 as new products and acquisitions come on…
Net sales grew 7.5% Y/Y to $5.44B, with adjusted EPS up to $0.86 and gross margin at 70.7%. Cardiovascular and neuromodulation segments led growth, while a $2B share repurchase and $1.5B MiRus investment marked significant capital moves.Original document: Boston Scientific Corporation [BSX] Slides…
MARLBOROUGH, Mass., July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported basis and 7.0 percent on an operational1 and organic2 basis, all compared to the prior year period. T…
Medical device company Boston Scientific NYSE:BSXwill be reporting earnings this Wednesday morning. Here’s what to expect.Boston Scientific beat analysts’ revenue expectations last quarter, reporting revenues of $5.20 billion, up 11.6% year on year. It was a softer quarter for the company, with rev…
Shares of SpaceX (SPCX), International Business Machines Corp. (IBM), and Boston Scientific Corp. (BSX) slumped to 52-week lows on Wednesday as profit-taking, weak outlook, and Wall Street concerns resulted in a selloff in the stocks.SPCX stock closed 0.6% lower amid profit-taking, cooling investor…
